Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gabriele Buda

Showing results (41-50 of 132) with videos related to

Pageof 14
Sort By:
Leukemia Research|April 27, 2007
Transitory marrow aplasia during Imatinib therapy in a patient with chronic myeloid leukemiaGiulia Cervetti, Giovanni Carulli, Sara Galimberti, et al.
Annals of Hematology|August 28, 2024
Light chain deposition disease: pathogenesis, clinical characteristics and treatment strategiesRaffaella Cassano Cassano, Angelo Giovanni Bonadio, Maria Livia Del Giudice, et al.
Leukemia Research|April 3, 2007
Reduction of immunoglobulin levels during imatinib therapy of chronic myeloid leukemiaGiulia Cervetti, Giovanni Carulli, Sara Galimberti, et al.
Acta Haematologica|August 26, 2015
CD229 Expression on Bone Marrow Plasma Cells from Patients with Multiple Myeloma and Monoclonal Gammopathies of Uncertain SignificanceGiovanni Carulli, Gabriele Buda, Antonio Azzarà, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|June 1, 2017
Cardiac light-chain deposition disease relapsing in the transplanted heartAlberto Aimo, Giuseppe Vergaro, Angela Pucci, et al.
European Journal of Haematology|November 26, 2019
Autologous stem cell transplantation is safe in selected elderly multiple myeloma patientsElisabetta Antonioli, Chiara Nozzoli, Gabriele Buda, et al.
Journal of Clinical Laboratory Analysis|January 16, 2025
Predictive Role of Soluble B-Cell Maturation Antigen in Short-Term Monitoring of Differently Treated Multiple Myeloma Patients: A Prospective StudyLaura Caponi, Maria Livia Del Giudice, Alice Botti, et al.
Leukemia Research|March 30, 2007
Complex translocation t(3;9;22)(q21;q34;q11) at diagnosis is a negative prognostic index in chronic myeloid leukemiaGabriele Buda, Enrico Orciuolo, Sara Galimberti, et al.
Leukemia Research|February 13, 2010
Abnormal phenotype of bone marrow plasma cells in patients with chronic myeloid leukemia undergoing therapy with ImatinibGiovanni Carulli, Elisa Cannizzo, Virginia Ottaviano, et al.
International Journal of Molecular Sciences|June 26, 2026
Early Soluble B-Cell Maturation Antigen (BCMA/TNFRSF17) Kinetics as a Molecular Biomarker of Treatment Response in Multiple Myeloma PatientsLaura Caponi, Maria Livia Del Giudice, Silvia Ursino, et al.
Pageof 14

Showing results (41-50 of 132) with videos related to

Sort By:
Pageof 14
Leukemia Research|April 27, 2007
Transitory marrow aplasia during Imatinib therapy in a patient with chronic myeloid leukemiaGiulia Cervetti, Giovanni Carulli, Sara Galimberti, et al.
Annals of Hematology|August 28, 2024
Light chain deposition disease: pathogenesis, clinical characteristics and treatment strategiesRaffaella Cassano Cassano, Angelo Giovanni Bonadio, Maria Livia Del Giudice, et al.
Leukemia Research|April 3, 2007
Reduction of immunoglobulin levels during imatinib therapy of chronic myeloid leukemiaGiulia Cervetti, Giovanni Carulli, Sara Galimberti, et al.
Acta Haematologica|August 26, 2015
CD229 Expression on Bone Marrow Plasma Cells from Patients with Multiple Myeloma and Monoclonal Gammopathies of Uncertain SignificanceGiovanni Carulli, Gabriele Buda, Antonio Azzarà, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|June 1, 2017
Cardiac light-chain deposition disease relapsing in the transplanted heartAlberto Aimo, Giuseppe Vergaro, Angela Pucci, et al.
European Journal of Haematology|November 26, 2019
Autologous stem cell transplantation is safe in selected elderly multiple myeloma patientsElisabetta Antonioli, Chiara Nozzoli, Gabriele Buda, et al.
Journal of Clinical Laboratory Analysis|January 16, 2025
Predictive Role of Soluble B-Cell Maturation Antigen in Short-Term Monitoring of Differently Treated Multiple Myeloma Patients: A Prospective StudyLaura Caponi, Maria Livia Del Giudice, Alice Botti, et al.
Leukemia Research|March 30, 2007
Complex translocation t(3;9;22)(q21;q34;q11) at diagnosis is a negative prognostic index in chronic myeloid leukemiaGabriele Buda, Enrico Orciuolo, Sara Galimberti, et al.
Leukemia Research|February 13, 2010
Abnormal phenotype of bone marrow plasma cells in patients with chronic myeloid leukemia undergoing therapy with ImatinibGiovanni Carulli, Elisa Cannizzo, Virginia Ottaviano, et al.
International Journal of Molecular Sciences|June 26, 2026
Early Soluble B-Cell Maturation Antigen (BCMA/TNFRSF17) Kinetics as a Molecular Biomarker of Treatment Response in Multiple Myeloma PatientsLaura Caponi, Maria Livia Del Giudice, Silvia Ursino, et al.
Pageof 14